Sensus Healthcare, Inc. (SRTS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q3 '16: 13.8M Q4 '16: 14.8M Q1 '17: 16.1M Q2 '17: 17.5M Q3 '17: 19M Q4 '17: 20.6M Q1 '18: 22.2M Q2 '18: 23.3M Q3 '18: 24.8M Q4 '18: 26.4M Q1 '19: 25.9M Q2 '19: 27.3M Q3 '19: 26.8M Q4 '19: 27.3M Q1 '20: 23.5M Q2 '20: 17.2M Q3 '20: 13M Q4 '20: 9.6M Q1 '21: 11M Q2 '21: 15.2M Q3 '21: 19.1M Q4 '21: 27M Q1 '22: 34.3M Q2 '22: 41M Q3 '22: 44.5M Q4 '22: 44.5M Q1 '23: 37.6M Q2 '23: 30.1M Q3 '23: 24.9M Q4 '23: 24.4M Q1 '24: 31.7M Q2 '24: 36.4M Q3 '24: 41.3M Q4 '24: 41.8M Q1 '25: 39.5M Q2 '25: 37.6M Q3 '25: 35.6M Q4 '25: 27.5M Q1 '26: 22.5M Q2 '26: 17.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '16: 8.9M Q4 '16: 9.8M Q1 '17: 10.8M Q2 '17: 11.9M Q3 '17: 12.8M Q4 '17: 13.8M Q1 '18: 14.9M Q2 '18: 15.4M Q3 '18: 16.4M Q4 '18: 16.9M Q1 '19: 16.3M Q2 '19: 17.3M Q3 '19: 17M Q4 '19: 17.6M Q1 '20: 15M Q2 '20: 10.7M Q3 '20: 7.5M Q4 '20: 5.2M Q1 '21: 6.1M Q2 '21: 8.8M Q3 '21: 11.4M Q4 '21: 17M Q1 '22: 22.6M Q2 '22: 27.5M Q3 '22: 30.1M Q4 '22: 29.6M Q1 '23: 24.1M Q2 '23: 18.5M Q3 '23: 14.6M Q4 '23: 14.1M Q1 '24: 19.1M Q2 '24: 21.9M Q3 '24: 25.2M Q4 '24: 24.4M Q1 '25: 22.1M Q2 '25: 19.6M Q3 '25: 17.1M Q4 '25: 11.9M Q1 '26: 8.5M Q2 '26: 6.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-18M -12M -6M 0 6M 12M 18M Q4 '16: -363.1K Q1 '17: -2M Q2 '17: -2.4M Q3 '17: -3.3M Q4 '17: -3.7M Q1 '18: -3.2M Q2 '18: -3M Q3 '18: -2.4M Q4 '18: -2M Q1 '19: -3.1M Q2 '19: -2.5M Q3 '19: -2.9M Q4 '19: -2M Q1 '20: -3.4M Q2 '20: -6M Q3 '20: -7.5M Q4 '20: -8.2M Q1 '21: -5.7M Q2 '21: -3.4M Q3 '21: -942K Q4 '21: 4.1M Q1 '22: 9.2M Q2 '22: 14M Q3 '22: 16M Q4 '22: 14.8M Q1 '23: 8M Q2 '23: 2.3M Q3 '23: -1.8M Q4 '23: -382K Q1 '24: 5.4M Q2 '24: 8.6M Q3 '24: 11.9M Q4 '24: 8.1M Q1 '25: 2.6M Q2 '25: -1.4M Q3 '25: -5.4M Q4 '25: -10.3M Q1 '26: -12M Q2 '26: -13.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-20M -10M 0 10M 20M 30M Q4 '16: -346.4K Q1 '17: -1.9M Q2 '17: -2.3M Q3 '17: -3.3M Q4 '17: -3.7M Q1 '18: -3.3M Q2 '18: -3M Q3 '18: -2.5M Q4 '18: -2M Q1 '19: -3M Q2 '19: -2.4M Q3 '19: -2.6M Q4 '19: -1.7M Q1 '20: -3.2M Q2 '20: -5.9M Q3 '20: -6.8M Q4 '20: -6.8M Q1 '21: -4.4M Q2 '21: -2.1M Q3 '21: -182K Q4 '21: 4.1M Q1 '22: 21.3M Q2 '22: 25.1M Q3 '22: 26.7M Q4 '22: 24.2M Q1 '23: 6.3M Q2 '23: 2.4M Q3 '23: -896K Q4 '23: 485K Q1 '24: 4.7M Q2 '24: 6.6M Q3 '24: 9.3M Q4 '24: 6.6M Q1 '25: 1.8M Q2 '25: -848K Q3 '25: -3M Q4 '25: -7.7M Q1 '26: -7.8M Q2 '26: -15.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q3 '16: 4.9M Q4 '16: 5M Q1 '17: 5.4M Q2 '17: 5.7M Q3 '17: 6.2M Q4 '17: 6.8M Q1 '18: 7.3M Q2 '18: 7.9M Q3 '18: 8.5M Q4 '18: 9.5M Q1 '19: 9.6M Q2 '19: 10M Q3 '19: 9.9M Q4 '19: 9.7M Q1 '20: 8.6M Q2 '20: 6.6M Q3 '20: 5.5M Q4 '20: 4.3M Q1 '21: 4.8M Q2 '21: 6.4M Q3 '21: 7.8M Q4 '21: 10.1M Q1 '22: 11.8M Q2 '22: 13.5M Q3 '22: 14.3M Q4 '22: 14.9M Q1 '23: 13.5M Q2 '23: 11.6M Q3 '23: 10.4M Q4 '23: 10.3M Q1 '24: 12.6M Q2 '24: 14.5M Q3 '24: 16.2M Q4 '24: 17.4M Q1 '25: 17.4M Q2 '25: 18M Q3 '25: 18.5M Q4 '25: 15.6M Q1 '26: 14M Q2 '26: 11.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q2 '16: -1.3M Q3 '16: -2.4M Q4 '16: -851K Q1 '17: -3.1M Q2 '17: -3.5M Q3 '17: -2.4M Q4 '17: -3.1M Q1 '18: -3.7M Q2 '18: -4.8M Q3 '18: -6.1M Q4 '18: -8.6M Q1 '19: -12.2M Q4 '20: -434K Q1 '21: -2M Q2 '21: -2.8M Q3 '21: 1.1M Q4 '21: -286K Q1 '22: 3.9M Q2 '22: 4.5M Q3 '22: 6.9M Q4 '23: -2.1M Q1 '24: -4.3M Q2 '24: -847K Q3 '24: 2.7M Q4 '24: -831K Q1 '25: 4.7M Q2 '25: 3.6M Q3 '25: 1.9M Q4 '25: 528K Q1 '26: -548K Q2 '26: -6.8M Q4 '16 Q4 '17 Q4 '18 Q2 '21 Q2 '22 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q2 '16: -1.6M Q3 '16: -2.8M Q4 '16: -1.1M Q1 '17: -3.3M Q2 '17: -3.7M Q3 '17: -2.6M Q4 '17: -3.3M Q1 '18: -4.1M Q2 '18: -5.3M Q3 '18: -6.9M Q4 '18: -9.4M Q1 '19: -12.8M Q4 '20: -793K Q1 '21: -2.3M Q2 '21: -3.1M Q3 '21: 940K Q4 '21: -414K Q1 '22: 3.8M Q2 '22: 4.3M Q3 '22: 6.7M Q4 '23: -2.4M Q1 '24: -4.6M Q2 '24: -1.1M Q3 '24: 2.1M Q4 '25: 332K Q1 '26: -740K Q2 '26: -7M Q4 '16 Q4 '17 Q4 '18 Q2 '21 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '16: 10.7M Q1 '17: 13.2M Q2 '18: 13.4M Q2 '19: 16.4M Q2 '20: 16.4M Q3 '20: 16.5M Q1 '21: 16.5M Q2 '21: 16.5M Q3 '21: 16.5M Q1 '22: 16.6M Q2 '22: 16.6M Q3 '22: 16.6M Q1 '23: 16.2M Q2 '23: 16.2M Q3 '23: 16.3M Q1 '24: 16.3M Q2 '24: 16.3M Q3 '24: 16.3M Q1 '25: 16.3M Q2 '25: 16.3M Q3 '25: 16.3M Q1 '26: 16.5M Q2 '26: 16.5M Q1 '17 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.20 -0.60 0.00 0.60 1.20 1.80 Q4 '16: -0.03 Q1 '17: -0.15 Q2 '17: -0.18 Q3 '17: -0.25 Q4 '17: -0.28 Q1 '18: -0.24 Q2 '18: -0.22 Q3 '18: -0.18 Q4 '18: -0.14 Q1 '19: -0.19 Q2 '19: -0.14 Q3 '19: -0.15 Q4 '19: -0.10 Q1 '20: -0.19 Q2 '20: -0.36 Q3 '20: -0.42 Q4 '20: -0.42 Q1 '21: -0.27 Q2 '21: -0.13 Q3 '21: -0.02 Q4 '21: 0.24 Q1 '22: 1.28 Q2 '22: 1.51 Q3 '22: 1.61 Q4 '22: 1.47 Q1 '23: 0.38 Q2 '23: 0.15 Q3 '23: -0.05 Q4 '23: 0.03 Q1 '24: 0.29 Q2 '24: 0.41 Q3 '24: 0.57 Q4 '24: 0.41 Q1 '25: 0.11 Q2 '25: -0.05 Q3 '25: -0.18 Q4 '25: -0.47 Q1 '26: -0.47 Q2 '26: -0.94 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.